JP2010528261A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010528261A5 JP2010528261A5 JP2010507474A JP2010507474A JP2010528261A5 JP 2010528261 A5 JP2010528261 A5 JP 2010528261A5 JP 2010507474 A JP2010507474 A JP 2010507474A JP 2010507474 A JP2010507474 A JP 2010507474A JP 2010528261 A5 JP2010528261 A5 JP 2010528261A5
- Authority
- JP
- Japan
- Prior art keywords
- gpr110
- antibody
- level
- sample
- epitope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101000718228 Homo sapiens Adhesion G-protein coupled receptor F1 Proteins 0.000 claims 43
- 102100026443 Adhesion G-protein coupled receptor F1 Human genes 0.000 claims 39
- 238000000034 method Methods 0.000 claims 22
- 206010060862 Prostate cancer Diseases 0.000 claims 15
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 15
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 12
- 201000005202 lung cancer Diseases 0.000 claims 12
- 208000020816 lung neoplasm Diseases 0.000 claims 12
- 210000002307 prostate Anatomy 0.000 claims 12
- 210000004072 lung Anatomy 0.000 claims 10
- 210000004369 blood Anatomy 0.000 claims 7
- 239000008280 blood Substances 0.000 claims 7
- 210000002966 serum Anatomy 0.000 claims 7
- 108010072866 Prostate-Specific Antigen Proteins 0.000 claims 6
- 102000007066 Prostate-Specific Antigen Human genes 0.000 claims 6
- 238000001514 detection method Methods 0.000 claims 6
- 210000001124 body fluid Anatomy 0.000 claims 5
- 239000010839 body fluid Substances 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 102000055600 human ADGRF1 Human genes 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 238000012216 screening Methods 0.000 claims 4
- 210000001519 tissue Anatomy 0.000 claims 4
- 239000003550 marker Substances 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 102000010956 Glypican Human genes 0.000 claims 2
- 108050001154 Glypican Proteins 0.000 claims 2
- 102100032530 Glypican-3 Human genes 0.000 claims 2
- 108050007237 Glypican-3 Proteins 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 238000005259 measurement Methods 0.000 claims 2
- 239000007790 solid phase Substances 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 102000023732 binding proteins Human genes 0.000 claims 1
- 108091008324 binding proteins Proteins 0.000 claims 1
- 239000000090 biomarker Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000003013 cytotoxicity Effects 0.000 claims 1
- 231100000135 cytotoxicity Toxicity 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 230000035899 viability Effects 0.000 claims 1
- 230000000007 visual effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91671907P | 2007-05-08 | 2007-05-08 | |
| PCT/US2008/005983 WO2008140774A2 (en) | 2007-05-08 | 2008-05-08 | Methods for diagnosing and treating prostate and lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010528261A JP2010528261A (ja) | 2010-08-19 |
| JP2010528261A5 true JP2010528261A5 (enExample) | 2011-08-25 |
Family
ID=40002842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010507474A Pending JP2010528261A (ja) | 2007-05-08 | 2008-05-08 | 前立腺癌および肺癌の診断および治療方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20130224209A1 (enExample) |
| EP (1) | EP2156184B1 (enExample) |
| JP (1) | JP2010528261A (enExample) |
| CN (1) | CN101918836B (enExample) |
| AU (1) | AU2008251877A1 (enExample) |
| CA (1) | CA2686954A1 (enExample) |
| WO (1) | WO2008140774A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5305361B2 (ja) | 2007-05-04 | 2013-10-02 | オプコ・ダイアグノスティクス・リミテッド・ライアビリティ・カンパニー | 流体コネクタおよびマイクロ流体システム |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| EP3360978A3 (en) | 2009-05-07 | 2018-09-26 | Veracyte, Inc. | Methods for diagnosis of thyroid conditions |
| JP2013528622A (ja) * | 2010-06-04 | 2013-07-11 | ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド | 炎症性障害の処置 |
| JP5909070B2 (ja) * | 2010-10-28 | 2016-04-26 | 国立大学法人 東京大学 | Ｇｓ共役受容体に対する医薬品候補化合物をスクリーニングする方法 |
| MY193914A (en) * | 2012-03-05 | 2022-11-01 | Oy Arctic Partners Ab | Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume |
| CN102914658A (zh) * | 2012-10-24 | 2013-02-06 | 高维强 | Crisp3蛋白在前列腺癌诊断和治疗中的应用 |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| SG11201605784YA (en) | 2014-01-17 | 2016-08-30 | Minomic Internat Ltd | Cell surface prostate cancer antigen for diagnosis |
| CN104090103B (zh) * | 2014-03-24 | 2016-08-31 | 福州市传染病医院 | 基于抗体修饰ZnSe纳米晶检测肝癌标志物GPC3的试剂盒 |
| US12326453B2 (en) | 2014-03-28 | 2025-06-10 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
| DK3123381T3 (da) * | 2014-03-28 | 2023-11-27 | Opko Diagnostics Llc | Sammensætninger og fremgangsmåder relateret til diagnose af prostatacancer |
| EP2944652A1 (en) * | 2014-05-13 | 2015-11-18 | Technische Universität München | Glypican-3-specific T-cell receptors and their uses for immunotherapy of hepatocellular carcinoma |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| WO2016011068A1 (en) | 2014-07-14 | 2016-01-21 | Allegro Diagnostics Corp. | Methods for evaluating lung cancer status |
| US20170335396A1 (en) | 2014-11-05 | 2017-11-23 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
| US11097005B2 (en) | 2014-12-15 | 2021-08-24 | The Brigham And Women's Hospital, Inc. | Use of cadherin-11 antagonists to treat metabolic disorders and/or increase insulin sensitivity |
| WO2016160545A1 (en) | 2015-03-27 | 2016-10-06 | Opko Diagnostics, Llc | Prostate antigen standards and uses thereof |
| CN112034185A (zh) * | 2020-09-11 | 2020-12-04 | 上海市胸科医院 | Gpr110、vegfr、cd34在鉴别肺腺癌亚型中的用途 |
| KR102730255B1 (ko) * | 2022-08-12 | 2024-11-15 | (주)맥시온 | 암 진단용 다중 바이오마커 및 이의 용도 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2795403B2 (ja) * | 1986-07-30 | 1998-09-10 | 株式会社 シノテスト | 免疫的測定方法及び装置 |
| DE69934694T2 (de) * | 1998-08-10 | 2007-10-04 | Agensys, Inc., Santa Monica | Bpc-1: ein ausgeschiedenes gehirnspezifisches protein das von prostata- und blasen-krebszellen exprimiert und ausgeschieden wird |
| EP1364012A2 (en) | 2000-11-08 | 2003-11-26 | Millennium Pharmaceuticals, Inc. | 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof |
| AU2002309583A1 (en) * | 2001-04-18 | 2002-11-05 | Protein Desing Labs, Inc. | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| WO2003009814A2 (en) * | 2001-07-25 | 2003-02-06 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| AU2002330482A1 (en) * | 2002-09-04 | 2004-03-29 | Perseus Proteomics Inc. | Method of diagnosing cancer by detecting gpc3 |
| US20070010726A1 (en) * | 2002-10-02 | 2007-01-11 | Alfred E. Mann Inst. For Biomedical Engineering At The University Of Southern California | Internal biochemical sensing device |
| JP2004279157A (ja) * | 2003-03-14 | 2004-10-07 | Rohto Pharmaceut Co Ltd | 癌病巣判定のためのキット並びに方法 |
| US20060094046A1 (en) * | 2004-02-11 | 2006-05-04 | Arie Abo | Compositions and methods relating to angiogenesis and tumorigenesis |
| CN1926433A (zh) * | 2004-03-03 | 2007-03-07 | 拜奥默里克斯公司 | 用于检测psa的可活化游离形式的方法及其用于诊断前列腺的良性病理学和前列腺的腺癌的用途 |
| CA2589782A1 (en) * | 2004-11-30 | 2006-06-08 | Veridex Llc | Lung cancer prognostics |
| US20060211059A1 (en) * | 2005-03-18 | 2006-09-21 | Taneja Samir S | Methods of improving screening, diagnosis and staging of prostate cancer using serum testosterone |
| JP2007075072A (ja) * | 2005-09-16 | 2007-03-29 | Satoshi Takahashi | プロサイモシンαの機能抑制用組成物を含む抗癌剤、およびプロサイモシンα遺伝子の発現抑制用組成物に含有される核酸 |
| EP1938104A2 (en) * | 2005-10-17 | 2008-07-02 | Institute for Systems Biology | Tissue-and serum-derived glycoproteins and methods of their use |
-
2008
- 2008-05-08 EP EP20080754314 patent/EP2156184B1/en not_active Not-in-force
- 2008-05-08 AU AU2008251877A patent/AU2008251877A1/en not_active Abandoned
- 2008-05-08 WO PCT/US2008/005983 patent/WO2008140774A2/en not_active Ceased
- 2008-05-08 CN CN200880023852.5A patent/CN101918836B/zh not_active Expired - Fee Related
- 2008-05-08 CA CA 2686954 patent/CA2686954A1/en not_active Abandoned
- 2008-05-08 JP JP2010507474A patent/JP2010528261A/ja active Pending
-
2013
- 2013-01-21 US US13/746,180 patent/US20130224209A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010528261A5 (enExample) | ||
| CA2853103C (en) | Point-of-care immunoassay for quantitative small analyte detection | |
| KR101051435B1 (ko) | 대장암 관련 마커를 이용한 대장암 진단 키트 및 이를 이용한 대장암 진단 방법 | |
| WO2001020333A1 (en) | Early cancer tumor marker | |
| JP2021505843A5 (enExample) | ||
| KR20080114689A (ko) | 증가된 ｂｃｌ-2에 의한 암의 발견 | |
| JP2012526544A5 (enExample) | ||
| WO2012027631A2 (en) | Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cells | |
| JP6847972B2 (ja) | 大腸がん診断用組成物と診断マーカー検出方法 | |
| JP2024059621A (ja) | がんの診断及び治療のための組成物及び方法 | |
| CN101566633A (zh) | 一种诊断评价或测定癌症并预知所述疾病严重性的方法 | |
| JP2007533985A5 (enExample) | ||
| CA2322023A1 (en) | A novel method of detecting and monitoring endometrial and uterine cancers | |
| KR20190013707A (ko) | 암 검출을 위한 뉴클레오솜-전사 인자 복합체의 용도 | |
| JP2020522501A (ja) | Ｔ−ｄｍ１による癌治療成績の予測方法 | |
| CN101539574A (zh) | Survivin抗体的应用及以其制备的食管癌免疫层析检测试纸条 | |
| EP1159614A4 (en) | DIAGNOSTIC METHOD FOR ASTHMA | |
| US20090176245A1 (en) | Rheumatoid Arthritis Test Method and Treating Method | |
| PT2274623E (pt) | Método para o diagnóstico de hipertensão arterial pulmonar | |
| JP5176239B2 (ja) | チトクロムｃの定量による非アルコール性脂肪性肝炎の非侵襲的な検査方法及び検査キット | |
| CN104330570A (zh) | 人热休克蛋白gp96在制备筛查肝病的产品中的应用 | |
| JP4476801B2 (ja) | 新生物の検出方法 | |
| JP2002526760A (ja) | 消化器癌を診断、監視、病期分類、イメージング及び治療する新規な方法 | |
| EP1802972A2 (en) | Method of detecting cancer based on immune reaction to boris | |
| JP4795353B2 (ja) | 腫瘍疾患および慢性炎症性腸疾患の診断のための液性バイオマーカーとしてのカルバモイルリン酸合成酵素１（ｃｐｓ１）の使用 |